… depressive disorders in the United States was estimated to be $83.1 billion (2). Current practice
guidelines for the treatment of major depressive disorder … with major depressive disorder. …

… safe. The substantial geographical variation in rates of use of ECT suggests uncertainty about
its efficacy and safety.3, 4 … the benefits and harms of ECT in the treatment of depression. …

… This meta-analysis focused on RCTs to examine the efficacy and safety of anti-inflammatory
agents as adjunctive treatment and monotherapy in patients with major depressive disorder. …

… to compare the efficacy and safety of curcumin with fluoxetine in patients with major depressive
disorder (MDD). … The primary efficacy variable was response rates according to Hamilton …

… in patients with major depressive disorder (MDD), but little is known about long-term outcomes.
… This study sought to examine the efficacy and safety of psilocybin through 12 months in …

… efficacy in treatment-resistant depression.The aim of this study was to compare the efficacy,
safety… (ADT) in the treatment of a major depressive episode in patients who have shown an in…

… This study evaluated the efficacy and safety of adjunctive aripiprazole or placebo to standard
antidepressant therapy (ADT) in patients with major depressive disorder who showed an …

… Areas covered: Esketamine’s efficacy and safety in TRD were … for showing efficacy, although
improvement in depressive … The main concerns relate to the safety aspects of prolonged …

… Objective: This study evaluated the efficacy and safety of desvenlafaxine succinate
extended-release in major depressive disorder (MDD). Method: Adult outpatients with DSM-IV–…

… the efficacy and safety of 2 fixed doses of agomelatine in patients with moderate to severe
major depressive disorder. Primary efficacy variable was the change in 17-item Hamilton …